ArticleJTCVS techniques2025
Aortoesophageal fistula: Long-term survival with aggressive multidisciplinary management.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Management of secondary aorto-oesophageal fistula after aortic arch replacement: a case report without aortic reconstruction.European heart journal. Case reports · 2026Article
- From Migration to Emergency: A Systematic Review of Acute Presentations Following Late Esophageal Stent Migration.Journal of clinical medicine · 2026Review
- Minimally invasive esophagectomy and omental transposition for the treatment of refractory aortoesophageal fistula.Journal of cardiothoracic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Aortoesophageal fistula (AoEF) is a rare but complex problem that carries high mortality. This study describes our institutional experience with the management of AoEF. Methods: There were 17 patients with AoEF who were managed in our center (2005-2023). Medical records were reviewed for baseline characteristics, history of esophageal or aortic disease, diagnostic evaluation, surgical treatment, and follow-up. Overall survival (OS) was analyzed using the Kaplan-Meier method and log rank tests. Results: Most patients had previous aortic operations (12/17, 71%)-7 thoracic endovascular aortic repair (TEVAR), 3 open/TEVAR, and 2 open repairs. The etiology of AoEF was aortic disease in 13 (76%) and anastomotic leak after esophagectomy in 4 (24%). Upon presentation, 2 (12%) patients were not offered intervention, whereas 6 (35%) had emergency TEVAR to control bleeding. Twelve (67%) patients were treated with curative intent, 1 patient did not survive an initial aortic operation. Of the remaining 11 patients, esophageal operations happened before aortic repair in 7 (64%), concurrently in 3 (27%), and after in 1 (9%). This included diversion esophagectomy in 7 (64%) and primary repair in 3 (27%). Definitive aortic surgery included aorta replacement with rifampin-soaked grafts in 8 (67%) and homografts in 4 (33%). In-hospital mortality occurred in 1 of 12 (8%) cases. One- and 2-year OS was 83% and 74%. OS was lower in patients not receiving curative-intent treatment ( Conclusions: Management of AoEF is complex. However, aggressive multidisciplinary intervention with definitive esophageal and aortic repairs can result in good long-term survival in selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.